Trial Profile

Efficacy and safety of dexamethasone nanoparticles eye drops in diabetic macular edema

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 08 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexamethasone (Primary)
Indications Diabetic macular oedema
Focus Proof of concept; Therapeutic Use
Sponsors Oculis Pharma

Most Recent Events

06 Sep 2022 According to an Oculis Pharma media release, the trial has been published in the Acta Ophthalmologica journal.
05 Oct 2020 Results presented in an Oculis Pharma media release.
05 Oct 2020 According to an Oculis Pharma media release, results from the study were presented at EURETINA 2020 Virtual during the Late Breaking & Reviews session by renowned retina specialist Prof. Ramin Tadayoni, M.D., Ph.D. who is also a member of Oculis's Scientific Advisory Board.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com